SKO-TRZ 15MG
$119.99 USD
Dual receptor agonist research peptide for in-vitro pathway studies.
SKO-TRZ is a synthetic dual receptor agonist research peptide supplied strictly for in-vitro and preclinical laboratory research. Studied in controlled experimental models for incretin receptor signaling, glucose-handling pathway assays, and lipid metabolism characterization. Premium Research Peptide. For research use only — not for human or animal consumption.
Available sizes
Third party tested with a certificate of analysis. Sold strictly for laboratory research use only, not for human or veterinary use. 21+.